PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 116 filers reported holding PMV PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,085,936 | +3.9% | 339,729 | +5.9% | 0.00% | – |
| Q2 2023 | $2,008,196 | +36.5% | 320,798 | +4.0% | 0.00% | – |
| Q1 2023 | $1,471,574 | -47.3% | 308,506 | -3.8% | 0.00% | -100.0% |
| Q4 2022 | $2,790,377 | -25.9% | 320,733 | +1.3% | 0.00% | 0.0% |
| Q3 2022 | $3,767,000 | -15.6% | 316,518 | +1.1% | 0.00% | 0.0% |
| Q2 2022 | $4,462,000 | -12.8% | 313,137 | +27.4% | 0.00% | 0.0% |
| Q1 2022 | $5,116,000 | -11.2% | 245,758 | -1.4% | 0.00% | 0.0% |
| Q4 2021 | $5,759,000 | -23.6% | 249,293 | -1.5% | 0.00% | 0.0% |
| Q3 2021 | $7,541,000 | -14.9% | 253,076 | -2.5% | 0.00% | -50.0% |
| Q2 2021 | $8,866,000 | +66.6% | 259,515 | +60.4% | 0.00% | +100.0% |
| Q1 2021 | $5,323,000 | -44.6% | 161,827 | +3.6% | 0.00% | -50.0% |
| Q4 2020 | $9,612,000 | +1595.2% | 156,278 | +878.1% | 0.00% | – |
| Q3 2020 | $567,000 | – | 15,978 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $74,726,000 | 44.17% |
| Euclidean Capital LLC | 2,336,909 | $53,983,000 | 30.69% |
| OUP Management Co., LLC | 989,232 | $22,851,000 | 10.30% |
| Nextech Invest Ltd. | 1,385,807 | $32,012,000 | 8.43% |
| Boxer Capital, LLC | 2,838,236 | $65,563,000 | 2.55% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $12,713,000 | 2.38% |
| Orbimed Advisors | 7,330,423 | $169,333,000 | 2.18% |
| Asymmetry Capital Management, L.P. | 97,680 | $2,256,000 | 1.20% |
| RTW INVESTMENTS, LP | 2,980,960 | $68,860,000 | 1.01% |
| HighVista Strategies LLC | 39,777 | $919,000 | 0.73% |